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Abstract
Background: Heterochromatin protein 1 (HP1) family proteins have a well-characterized role in heterochromatin
packaging and gene regulation. Their function in organismal development, however, is less well understood. Here
we used genome-wide expression profiling to assess novel functions of the Caenorhabditis elegans HP1 homolog
HPL-2 at specific developmental stages.
Results: We show that HPL-2 regulates the expression of germline genes, extracellular matrix components and
genes involved in lipid metabolism. Comparison of our expression data with HPL-2 ChIP-on-chip profiles reveals
that a significant number of genes up- and down-regulated in the absence of HPL-2 are bound by HPL-2.
Germline genes are specifically up-regulated in hpl-2 mutants, consistent with the function of HPL-2 as a repressor
of ectopic germ cell fate. In addition, microarray results and phenotypic analysis suggest that HPL-2 regulates the
dauer developmental decision, a striking example of phenotypic plasticity in which environmental conditions
determine developmental fate. HPL-2 acts in dauer at least partly through modulation of daf-2/IIS and TGF-b
signaling pathways, major determinants of the dauer program. hpl-2 mutants also show increased longevity and
altered lipid metabolism, hallmarks of the long-lived, stress resistant dauers.
Conclusions: Our results suggest that the worm HP1 homologue HPL-2 may coordinately regulate dauer diapause,
longevity and lipid metabolism, three processes dependent on developmental input and environmental conditions.
Our findings are of general interest as a paradigm of how chromatin factors can both stabilize development by
buffering environmental variation, and guide the organism through remodeling events that require plasticity of cell
fate regulation.
Background
In most organisms, including mammals, environmental
and physiological signals are integrated to regulate
metabolism, development and life span. In eukaryotes,
these processes are often associated with characteristic
epigenetic changes brought about by the activity of
chromatin-associated proteins and enzymes that influ-
ence the transition between chromatin states, thereby
influencing transcriptional activity.
Among the more universally conserved epigenetic fac-
tors are members of the Heterochromatin protein 1
(HP1) family. These contribute directly to the formation
of nuclear heterochromatic domains, including telo-
meres and centromeres, through an interaction with tri-
methylated lysine 9 of histone H3 (H3K9me3) [1,2].
Both H3K9 methylation and HP1 binding at pericentro-
meric regions play a crucial role in chromosome segre-
gation during mitosis [3,4]. Within euchromatic regions,
however, the function of HP1 proteins in the control of
gene expression is complex. This involves interactions
with other proteins or RNA components, and leads to
either gene activation or repression depending on the
chromatin context [5-7].
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In many cases, the euchromatic functions of HP1
appear to be specific to different homologues within a
species, which display dramatic differences with respect
to subcellular localization and function. Drosophila
HP1a acts as positive regulator of transcription by facili-
tating H3K36 demethylation through an interaction with
the dKDM4A demethylase [8], while HP1c interacts
with two related transcription factors, WOC and ROW,
on active chromatin domains [9]. HP1a also functions in
gene activation through association with nascent tran-
scripts [10], while HP1c was found to link the histone
chaperone complex FACT to active RNA polymerase II
[11]. In mammals, the binding of HP1g upstream of
euchromatic genes is associated with silencing [12],
while its association within the coding region of genes
was found to affect transcriptional elongation [13].
More recently, HP1g and H3K9 tri-methylation were
also found to be associated with alternative splicing [14].
Although these studies suggest a role for HP1 family
members at both heterochromatic and euchromatic
sites, HP1’s essential role in centromere function has
confounded analysis of its role in development of most
species. In Drosophila, for example, mutations in HP1a
are associated with severe chromosome segregation
defects due to a perturbation of centromeric heterochro-
matin [15]. The ensuing early larval lethality obscures
other defects in gene regulation in the homozygous
mutant, and renders a systematic analysis of HP1a func-
tion in fly development very difficult. Nonetheless, this
early lethality could be bypassed by the conditional
RNA interference (RNAi) inactivation of HP1 in trans-
genic flies. This resulted in a preferential lethality of
males, due to the sex-specific regulation of genes encod-
ing cell cycle regulators [16]. Intriguingly, cell type-spe-
cific effects have also been ascribed to the various HP1
homologues in mammals. Both in vivo localization and
RNAi studies show that they play distinct roles in the
differentiation of different cell types [17-20]. The specifi-
city and sub-nuclear distribution of each homologue
appears to be influenced by humoral signals and micro-
environmental cues [21].
Exploiting the holocentric nature of Caenorhabditis
elegans chromosomes, we are able to examine the role
of HP1 during worm development without having to
subvert an essential role in centromere stability. We
have previously shown that deletion of the C. elegans
hpl-2 gene, which encodes an HP1 homologue, results
in temperature-sensitive non-lethal developmental
abnormalities, including defects in vulval cell-fate speci-
fication, and desilencing of repetitive arrays in the germ-
line [22,23]. Consistent with the holocentric nature of C.
elegans chromosomes, no defects in chromosome segre-
gation were observed in hpl-2 loss-of-function mutants
[22,24,25]. However, in vulval cell-fate specification,
HPL-2 appeared to act through repression of specific
genes, including lin-3/EGF inducer and lin-39/HOX
[26]. In the present study, expression microarray analysis
was performed using hpl-2 null mutants at embryonic
and larval developmental stages. At the L3 larval stage,
when the germline develops, germline-enriched genes
are found to be overexpressed in hpl-2 mutant animals.
This is consistent with a role for HPL-2 in preventing
ectopic expression of germline genes in the soma
[27,28], and/or a repressive function in the germline
[22]. Intriguingly, transcripts that are down-regulated in
the absence of hpl-2 at the larval stage stem from genes
involved in extracellular matrix-related functions and in
lipid metabolism and transport. Comparison of our
expression data with HPL-2 chromatin immunoprecipi-
tation (ChIP)-on-chip profiles available through the
modENCODE Consortium [29] shows that several of
these genes are bound by HPL-2, suggesting a regulatory
function.
This analysis has revealed a significant overlap
between HPL-2-regulated genes and genes whose
expression is altered in dauer diapause, an alternative
developmental program that worms undergo under
stressful conditions. We find that hpl-2 interacts geneti-
cally with both the transforming growth factor (TGF)-b
and the insulin/insulin-like growth factor-I-like receptor
(IIR) signaling pathways, which are the major determi-
nants of dauer formation [30]. Moreover, the dauer exit
process can be restored by expressing HPL-2 in either
neuronal or intestinal cells. Altogether, this suggests
that HPL-2 regulates both the decision to enter and exit
this developmental stage, as well as controlling the tis-
sue remodeling that accompanies the dauer state.
We are able to attribute additional phenotypes related
to dauer to HPL-2 function. Specifically, hpl-2 mutants
show an increased lifespan that is dependent on both
daf-2 and the downstream transcription factor daf-16/
FOXO, mimicking dauer-constitutive mutants of the
daf-2/IIR pathway. At the same time, hpl-2 mutant ani-
mals show significant alterations in specific aspects of
lipid metabolism, mediated at least in part through the
regulation of key phospholipid metabolism enzymes. We
suggest that these in turn influence lifespan through the
regulation of lipid homeostasis. Together, our data sug-
gest that rather than globally affecting the expression of
a large number of genes, HPL-2 specifically controls
genes whose expression impinges on the highly inter-
twined processes of dauer development, longevity and
lipid metabolism.
Results
Overview of stage-specific transcriptional responses
Previous studies have suggested biological roles for
HPL-2 at larval stages of C. elegans growth, while no
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obvious defects in embryonic development were
observed in its absence [24]. To detect changes relevant
for the hpl-2 phenotypes, we carried out DNA microar-
ray experiments comparing expression profiles of wild-
type and hpl-2 loss-of-function worms grown at 20°C
and synchronized at the embryonic or L3 larval stages.
To analyze the microarray data, we applied a statistical
threshold with a cutoff of P < 0.05 (empirical Bayes sta-
tistics) and a fold change > 1.5 for mutant versus wild-
type samples. The curated list of genes showed a total
of 1,794 embryonic transcripts and 1,160 L3 stage tran-
scripts that were misregulated at least 1.5-fold in the
hpl-2 mutant background compared to wild-type ani-
mals (Additional file 1; NCBI [GSE33700]). To further
validate the array findings, 12 genes with different devel-
opmental expression patterns and different biological
functions were selected as targets for RT-PCR (Figure
1a). For all 12 genes, a good correlation between micro-
array data and quantitative PCR (qPCR) expression
values was observed. Of the total number of responsive
genes (2,954), only 5.6% were found to be misregulated
at both developmental stages (Figure 1b), confirming
that HLP-2 has distinct biological roles at different
stages of development. Although the vast majority of
commonly regulated genes encode proteins of unknown
function, a notable exception is lin-13, which was up-
regulated in both embryos and larvae. LIN-13 is a zinc
finger protein required for HPL-2 recruitment to
nuclear foci in embryos [23]. This indicates that a com-
plex feedback control exists between HPL-2 and the
important lineage factor LIN-13. Analysis of lin-13
expression in vivo using a green fluorescent protein
(GFP) translational fusion revealed strongly increased
GFP expression in hpl-2 mutant animals compared to
wild type, further validating microarray results (Addi-
tional file 2).
In embryos, significantly more genes were down-regu-
lated than up-regulated (1,344 and 450, respectively) in
the absence of HPL-2, while approximately the same
number of genes were found in each class in L3 larvae
(615 and 545, respectively; Figure 1b). Although some of
the down-regulated genes are likely to be indirect tar-
gets, these results suggest that HPL-2 may also play a
significant role in gene activation, as reported for certain
other HP1 family proteins in both Drosophila and mam-
malian cells [5,11,13,31,32].
To analyze the responsive genes in more depth, they
were divided into functional categories based on gene
ontologies (GOs; Table 1). In embryos, up-regulated
genes are slightly enriched in GO terms associated with
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Figure 1 Validation of microarray results and overlap between embryonic and larval gene sets. (a) Correlation between results obtained
by microarray and quantitative RT-PCR (qRT-PCR) for selected genes in embryos and L3 larvae. For qRT-PCR expression values, data are the
mean of three independent biological replicas. Error bars indicate standard deviation. pmp-3 and cdc-42 were used for normalization and the
RNA level of each gene of interest was normalized to the mean of both reference genes. (b) Venn diagram showing overlap between up- and
down-regulated genes in embryonic and L3 larval stages.
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lipid metabolic processes (Fisher exact test (FET) P =
0.043), while down-regulated genes are enriched in GO
terms associated with RNA metabolic processes (FET P
= 2 × 10-6). L3 up-regulated genes are significantly
enriched in GO terms associated with meiotic functions
(FET P = 4 × 10-6). The expression of many of these
same genes is enriched in the germline (Additional file
3a) and is likely to reflect the role of HPL-2 and other
chromatin-associated proteins in the repression of germ
cell fate in the soma [28,33]. However, as our microar-
ray analysis was performed on whole animals, some of
these genes might also be up-regulated in the germline,
where HPL-2 plays a role in germline transgene silen-
cing and the related phenomenon of germline co-sup-
pression [22,34].
The genes that are down-regulated in L3 larva by loss
of HPL-2 activity are enriched in GO terms associated
with alcohol metabolic processes (FET P = 0,003), trans-
port (FET P = 0,003), and lipid metabolism (FET P =
0,004). Intriguingly, visual inspection of the data
revealed that four classes of genes (abu, nas, fipr, nspb)
that are specifically down-regulated at this larval stage
are tightly grouped together in mountain 29 of the C.
elegans three-dimensional topographical expression map
[35] (Additional file 3c). These genes may, therefore, be
coordinately regulated by HPL-2. Because all of the phe-
notypes associated with hpl-2 loss of function concern
post-embryonic development, we specifically focused
our attention on genes showing altered expression at
the L3 stage, as we considered these genes as those
most likely to be directly responsible for stage-specific
phenotypes.
Comparison of our expression data with HPL-2 ChIP-
on-chip profiles obtained in wild-type L3 larvae (avail-
able through the modENCODE Consortium [29])
revealed that a significant number of genes up- and
down-regulated in the absence of HPL-2 are bound by
HPL-2 (Additional file 4; up-regulated genes FET = 6.7
× 10-8; down-regulated genes FET = 1.2 × 10-4). ChIP-
qPCR analysis confirmed HPL-2 enrichment on a subset
of these genes (Figure 2). HPL-2 binding was found
both within promoter and coding regions. No correla-
tion was found between promoter or internal binding
and either repression or activation of the bound gene in
the absence of HPL-2. Therefore, HPL-2 may regulate
gene expression by more than one mechanism and in a
context-dependent manner, as observed for other HP1
family proteins [7,14,36].
In most organisms HP1 binds methylated H3K9 [1,2].
This interaction appears to be conserved in C. elegans,
as heterochromatin-like transgenic arrays enriched in
methylated H3K9 require HPL-2 for repression
[22,37,38]. ChIP analysis confirmed that both H3K9me3
and HPL-2 are enriched on these arrays (Additional file
5). We therefore compared our expression data with
ChIP-on-chip profiles of H3K9me1/2/3 in wild-type L3
larvae, also available through the modENCODE Consor-
tium [29]. We reasoned that this approach might help
identify genes whose expression is directly regulated by
the binding of HPL-2 to methylated H3K9. For each
gene list, we calculated the median H3K9me1/2/3 signal
over the gene body or the promoter and compared this
value to the values obtained for expression-level
matched genes. We then plotted the distribution of
these median signals as box-whisker representation. In
this representation, the bar indicates the median for dis-
tribution over genes and the upper and lower edges of
the box represent the 25th and 75th percentile, respec-
tively. For the genes that require HPL-2 for full repres-
sion, we observe a significantly higher signal for H3K9
Table 1 Enrichment for Gene Ontology terms among hpl-2-regulated genes
Term Count P-value Fold enrichment
Embryo down-regulated
GO:0006396 - RNA processing 23 4.37E-05 2.7
GO:0006796 - phosphate metabolic process 48 0.017 1.4
Embryo up-regulated
GO:0006631 - fatty acid metabolic process 4 0.043 5
L3 down-regulated
GO:0009712 - catechol metabolic process 5 3E-03 8.0
GO:0043043 - peptide biosynthetic process 4 0.02 8.0
GO:0046942 - carboxylic acid transport 5 3E-03 8.0
GO:0006631 - fatty acid metabolic process 3 0.04 5.0
L3 up-regulated
GO:0007126 - meiosis 15 3.21E-06 4.7
GO:0022402 - cell cycle process 19 3.12E-05 3.1
GO:0045132 - meiotic chromosome segregation 12 3.22E-05 4.0
Gene Ontology (GO) terms are from the biological process ontology. GO information was downloaded from DAVID [110]. In some cases, more specific subtypes
of the listed parental terms were also significantly enriched.
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mono- and di-methylation, and to a lesser extent tri-
methylation, compared to expression-matched promo-
ters and gene bodies from wild-type cells (Additional
file 6; Wilcoxon test P = 10-89, 10-83, 10-34, respectively,
for promoters, 10-44, 10-39 and 10-18, respectively, for
gene bodies). This suggests that at least part of the dere-
pression in hpl-2 mutant larvae is indeed direct, that is,
due to HPL-2 binding to methylated H3K9. For genes
that show lower expression levels in the hpl-2 mutant,
the correlation with methylated H3K9 was much
weaker, suggesting indirect effects on gene expression,
or possibly the existence of alternative mechanisms for
recruiting HPL-2 to euchromatic sites. One such
mechanism may be through the LIN-13 zinc finger pro-
tein [23].
hpl-2 regulates a subset of dauer genes
Visual inspection revealed that both up- and down-
regulated transcripts in hpl-2 mutant animals show a
significant overlap with genes regulated in animals
undergoing dauer arrest [39] (Figure 3a, b; FET P < 2
× 10-6). In a favorable environment, C. elegans devel-
ops into an adult through four larval stages (L1 to L4),
but in response to starvation or overcrowding, larvae
arrest development at the second molt (L2) to form
dauer larvae. Dauer animals are non-feeding and
stress-resistant, and can remain in this state for
months until environmental conditions become favor-
able again. Dauer formation has been widely used as a
model to study the regulatory mechanisms governing
morphological change during organismal development
[40]. The list of genes whose expression changes dur-
ing dauer arrest was obtained by comparing expression
profiles of wild-type larvae at the L2/L3 larval stage
transition to animals undergoing dauer larva formation
(pre-dauer L2d/dauer). Our data were obtained from a
very similar developmental stage (early L3), which
makes the observed overlap particularly relevant. Sig-
nificantly, we also observed overlap between genes up-
regulated during dauer exit [41] and genes down-regu-
lated in the absence of hpl-2 (FET P = 2 × 10-16; Addi-
tional file 3b).
The commonly regulated genes fall into four classes.
The first class includes genes encoding collagens and
metalloproteases involved in the synthesis and degra-
dation of the extracellular matrix and cuticle physiol-
ogy [39,42,43]. The second group consists of members
of the Hedgehog (Hh)-related-family, which are down-
regulated in both data sets. The nematode Hh-related
genes encode secreted proteins mostly expressed in the
epidermis, which secretes the lipid- and collagen-rich
cuticle, and in neurons and neuronal support cells
required for the response to the environment [44-46].
Consistent with a possible role of these proteins in
cuticle formation, inactivation of some Hh-related
genes causes cuticle abnormalities and molting defects
[45,46]. The co-regulation of Hh-related genes and
structural components of the cuticle suggest that these
genes could regulate the production of the dramatically
different cuticles of dauer and reproductive L3 [47]
through coordinated regulation by HPL-2. The third
class of dauer and hpl-2-sensitive genes comprises a
number of transporters whose expression is reduced
upon dauer entry. These include members of the ABC
transporter superfamily (pgp-5, 7 and 12), and mem-
bers of the MSF1 Major facilitator superfamily
(F09A5.1, F14D7.6 and F53H8.3). Finally, the fourth
and last class consists of cytochromes, enzymes
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Figure 2 HPL-2 binding to target genes. Worm extracts from synchronized L3 worms were subjected to immunoprecipitation (IP) using either
HPL-2-specific antibodies or pre-immune serum as control. For each gene tested, a cartoon shows the position of the primers used for
quantitative PCR (qPCR) analysis and a histogram representing the fold-enrichment, calculated as the ratio between signal from the antibodies
and signal from pre-immune serum, from chromatin immunoprecipitation (ChIP) experiments along the gene. chIV is a primer from an
intergenic region on chromosome IV used as an internal control. Similar results were obtained for two to three independent experiments.
Meister et al. Genome Biology 2011, 12:R123
http://genomebiology.com/2012/12/12/R123
Page 5 of 18
involved in protection from toxins, hormone biosynth-
esis and other functions. Of the 81 members of the
P450 family in C. elegans, 8 are present in the hpl-2
microarray. Three of these (cyp-33C9, cyp-14A5, and
cyp-37B1) are down-regulated in hpl-2 mutants and in
dauer, while two (cyp-25A2 and cyp13A5) are up-regu-
lated in hpl-2 mutants and upon dauer entry [39,48].
Genes from each of these classes are also induced
upon dauer exit [41], suggesting an important function
in the regulation of both dauer entry and exit pro-
grams. HPL-2 binding and H3K9 methylation could be
detected on a number of these dauer-regulated genes,
including cdh-10, cdh-12, Y55F3AM.14, and srr-2 [49]
(Figure 2), suggesting that they are likely to be direct
targets of HPL-2.
HPL-2 influences dauer entry and exit
The above results prompted us to test whether hpl-2
mutants are associated with dauer phenotypes. High
temperature (27°C), scarce food and a secreted dauer
pheromone influence dauer formation. While higher
temperatures alone failed to induce a dauer phenotype
in hpl-2 animals, when plates with identical bacterial
lawns were seeded with the same number of worms at
25°C, we observed that starved plates containing hpl-2
mutant worms reproducibly had many more dauers
than wild-type plates (data not shown). While this is not
a quantitative assay, the observation nonetheless sug-
gested that hpl-2-deficient animals enter dauer more
easily under starved and crowded conditions at 25°C.
We therefore tested whether hpl-2 mutants are more
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sensitive to dauer pheromone, an indicator of popula-
tion density produced by the worms, which induces
dauer formation at high concentrations.
At pheromone concentrations that trigger dauer for-
mation in 23% of wild-type animals after 48 hours at 25°
C, 97% of hpl-2 mutant animals entered dauer (Figure
3c). Therefore, hpl-2 mutants are associated with a
hypersensitivity to dauer pheromone, which becomes
evident under strong dauer-inducing conditions. When
shifted to 20°C following exposure to dauer pheromone,
a large majority of wild-type worms exit the dauer stage
after 2 to 3 days. In contrast, only 15 to 20% of hpl-2
mutant worms exit dauer under the same conditions.
We conclude that hpl-2 mutants exhibit both dauer
entry and exit defects, namely hypersensitivity for dauer
entry and a failure to exit efficiently.
The second C. elegans HP1 homologue, hpl-1, acts
redundantly with hpl-2 in postembryonic development
[24]. However, hpl-1 does not appear to act either alone
or redundantly with hpl-2 in dauer development, since
dauer formation was not impaired in either hpl-1
(tm1624) single or hpl-1(tm1624);hpl-2(tm1489) double
mutants at any of the temperatures tested.
HPL-2 synergizes with the DAF-2/IIS pathway for dauer
entry and exit
We next tested whether hpl-2 interacts genetically with
either of the well-characterized dauer pathways: DAF-2/
insulin-like signaling (IIS) and DAF-7/TGF-b. Mutations
in either of these pathways have been isolated as dauer
constitutive (daf-c), forming dauers even under non-
dauer-inducing conditions [50]. We first constructed
double mutants with the daf-2(e1370) allele, a well-
established sensitized background for assaying a weak
dauer phenotype [51]. While daf-2 single mutants do
not form dauer at 20°C, 10 to 20% of double hpl-2;daf-2
mutants entered dauer at this temperature (Figure 3d,
20°C). This difference between single and double
mutants was not detected at 22°C, a temperature at
which single daf-2(e1370) mutants all enter dauer for
approximately 3 days, then recover and resume develop-
ment to become reproductive adults (data not shown).
However, 3 days after egg-laying, when only 30% of the
daf-2 single mutants remained as dauers, 98% of hpl-2;
daf-2 double mutants were still in the dauer stage (Fig-
ure 3d, 22°C). Under these conditions, the block per-
sisted for more than two weeks. At a slightly higher
temperature, 25°C, 100% of the population remained in
the dauer stage in both genetic backgrounds after 3 days
(Figure 3d, 25°C). We conclude, therefore, that hpl-2
significantly enhances the dauer phenotype of daf-2
mutants.
Like daf-2(e1370) mutants, daf-7(e1372) mutants show
a temperature-sensitive dauer constitutive phenotype
[52]. At the semi-permissive temperatures of 15°C and
20°C, hpl-2;daf-7 double mutant animals show a greatly
enhanced dauer arrest phenotype compared to single
daf-7 mutants (Figure 3e). Our results thus suggest that
HPL-2 acts in parallel or downstream to the IIS and
TGF-b pathways to influence dauer through the regula-
tion of genes important for both dauer entry and dauer
exit processes. Given that this is a stress-induced differ-
entiation event, our results implicate HPL-2 in commu-
nication between environment and a chromatin-
controlled genetic response to stress.
HPL-2 acts in the nervous system and intestine to
influence dauer development
The decision to enter dauer is triggered by chemosen-
sory stimuli. Two major head sensory organs, called
amphids, are critical to dauer formation and both DAF-
28/insulin and DAF-7/TGF-b are expressed in a subset
of sensory neurons to impact dauer development
[53-55]. These hormones in turn regulate the activity of
widely expressed downstream receptors and transcrip-
tion factors, which regulate dauer remodeling in other
tissues. To establish in which tissue HPL-2 acts to influ-
ence dauer development, we carried out tissue-specific
rescue experiments on hpl-2;daf-2(e1370) animals raised
at 22°C (Figure 3f). While at this temperature all daf-2
animals reenter the reproductive cycle after 7 days, less
than 1% of the double hpl-2;daf-2 mutants ever exit the
dauer stage. Expression of hpl-2 under the control of
either the pan neuronal rab-3 promoter or the intestinal
ges-1 promoter allowed more than 30% of hpl-2;daf-2
(e1370) mutant animals to exit the dauer stage. By con-
trast, expression of hpl-2 under the control of the lin-31
promoter, which is expressed in vulval precursor cells,
failed to promote rescue. Furthermore, we confirmed
that GFP expression of the rab-3p::GFP::hpl-2 rescuing
transgene was limited to neuronal cells in hpl-2;daf-2
mutants (Additional file 7). These results suggest that
the rescue observed with the rab-3 and ges-1 promoters
is unlikely to be due to ectopic expression in additional
cell types, but reflects the tissue-specific expression of
these transgenes. The fact that rescue is partial could
stem from insufficient induction of these promoters
during dauer and/or from additional expression require-
ments in other tissues. Neuronal and intestinal expres-
sion together did not result in better rescue, however,
suggesting that in these tissues HPL-2 does not have
additive functions, but acts in the same process.
hpl-2 modulates lifespan through the IIS pathway
Our results suggest that hpl-2 synergizes with the IIS
pathway to control dauer development. Given that the
IIS pathway is also a well-established regulator of life-
span in C. elegans, Drosophila and mice [56], we
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performed lifespan analysis of hpl-2 null mutants at the
permissive temperature (20°C). We observed a reprodu-
cible increase in the mean lifespan of hpl-2 animals by
17% on average (average lifespan: hpl-2(tm1489), 15.1 ±
0.31 days (n = 287); wild-type, 12.9 ± 0.25 days; log
rank test P < 10-3; Figure 4a). To confirm that the
increased lifespan is due to inactivation of hpl-2 and not
to a background mutation, we repeated lifespan assays
of animals in which hpl-2 was inactivated by RNAi feed-
ing. hpl-2(RNAi) only partially inactivates hpl-2 activity
and compared to hpl-2 loss of function results in weaker
phenotypes only apparent at higher temperatures
[22,23]. However, similarly to the hpl-2 mutant, longev-
ity of hpl-2(RNAi) animals raised at 20°C and shifted to
25°C at the L4 stage was extended by 18% on average
compared to control animals (Additional file 8), con-
firming that HPL-2 is required for normal longevity.
Lifespan extension in the absence of HPL-2 is unlikely
to be related to a germline proliferation defect, as hpl-2
mutants have a wild-type brood size and germline cell
number at 20°C [22,23] (Additional file 9).
To assess whether the lifespan increase observed in
hpl-2 mutants depends on the IIS pathway, we analyzed
the lifespan of hpl-2;daf-2 double mutants. The two-fold
increase in lifespan of daf-2(e1370) mutants was
unchanged in hpl-2;daf-2 animals (average lifespan: daf-
2(e1370), 26.2 ± 0.85 days (n = 95); daf-2(e1370);hpl-2
(tm1489), 24.8 ± 0.97 days (n = 84); log rank test P =
0.271; Figure 4b). Therefore, the hpl-2 lifespan pheno-
type may rely on IIS signaling. The transcription factor
DAF-16/FOXO acts downstream of daf-2/IIR and is
essential for lifespan extension by daf-2. We therefore
tested whether the hpl-2 mutant lifespan phenotype also
requires DAF-16/FOXO. hpl-2(tm1489);daf-16(mu86)
mutants had a lifespan indistinguishable from that of
daf-16(mu86) alone, which is 16% shorter than wild-
type worms (average lifespan: daf-16(mu86), 11.9 ± 0.44
days (n = 112); daf-16(mu86);hpl-2(tm1489), 11.03 ±
0.27 days (n = 109); log rank test P = 0.05; Figure 4c).
Furthermore, the hpl-2 effect on longevity is not due to
altered expression of genes encoding proteins involved
in the IIS pathway, as the levels of daf-16 and other
major components of the pathway, including daf-2, age-
1, akt-1, akt-2 and daf-18, were not altered in hpl-2
mutants (Additional file 1). Taken together, our results
suggest that hpl-2 requires the activity of daf-16 to
modulate longevity in C. elegans and that hpl-2 may be
a novel co-regulator of daf-16-controlled genes.
To better define this relationship, we looked for over-
lap with the 514 genes that microarray analysis by Mur-
phy et al. [57] found to be modulated by DAF-16; 46 of
the genes that we found to be misregulated in the
absence of hpl-2 activity overlap with genes regulated by
DAF-16. Of these, 16 are genes repressed in hpl-2 and
in long-lived daf-2 pathway mutants, and activated in
daf-2;daf-16 mutants, reflecting DAF-16 dependence
(Additional file 2e; P = 0.003). We also compared our
dataset to a recent transcriptional profile to identify
genes whose expression changes over the C. elegans life-
span [58]. Out of 1,217 ageing-associated genes, 66 were
down-regulated in the absence of hpl-2, representing a
significant enrichment (Figure S2f; P = 5 × 10-7). Taken
together, these analyses suggest that the effect of hpl-2
on longevity may be mediated, at least in part, through
the regulation of longevity-associated genes, some of
which may be DAF-16-dependent.
hpl-2 mutants do not show altered daf-16 localization or
increased stress resistance
Similar to mammalian FOXO transcription factors,
translocation of DAF-16 from the cytoplasm to the
nucleus is required for activation, and has been observed
in animals with reduced DAF-2/IIS signaling and in
response to stresses such as heat shock or starvation
[59]. Using a previously described DAF-16::GFP reporter
[60], we observed no change in DAF-16 localization in
animals lacking HPL-2 (data not shown and Additional
file 10). Therefore, HPL-2 does not appear to impinge
on longevity by altering DAF-16 localization.
Many long-lived mutants also exhibit increased resis-
tance to environmental stress. However, hpl-2 mutants
are not significantly more resistant to oxidative stress, as
measured on paraquat (Additional file 11), and are
intrinsically thermosensitive. Therefore, the increased
longevity of hpl-2 mutants appears to be uncoupled
from increased resistance to environmental stressors, as
already observed in other contexts [55,61-64]. Consis-
tently, we did not observe increased expression of genes
commonly associated with increased stress resistance -
for example, the mtl-1 metallothionein gene and the
mitochondrial sod-3 superoxide dismutase gene - while
expression of the heat shock proteins hsp-16 and hsp-12
actually decreased [65-67] (Additional file 1).
hpl-2 regulates fat metabolism
Adipose tissue has been implicated in the regulation of
longevity in a number of species [68-70]. In C. elegans,
lipid hydrolysis in fat storage tissue was recently shown
to prolong life span, connecting the metabolic functions
of adipose tissue to lifespan control [71]. Genes asso-
ciated with fatty acid metabolism are over-represented
in the set of hpl-2 down-regulated genes (Table 1),
prompting us to test whether hpl-2 mutants may have
defects in lipid metabolism that could contribute to the
longevity phenotype. Down-regulated genes include the
fat-7 Δ9 fatty acid desaturase, acs-2, an acyl-CoA
synthetase, and ech-1, an enoyl-CoA hydratase. hpl-2
mutants raised at the non-permissive temperature are
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Figure 4 HPL-2 modulates lifespan by acting through the daf-2/IIS pathway. (a) Survival curve of wild-type and hpl-2(tm1489) animals. hpl-
2(tm1489) mutation increases average lifespan by 17% (average lifespan: hpl-2(tm1489), 15.1 ± 0.31 days (n = 287); wild type (WT), 12.9 ± 0.25
days (n = 280); log rank test P < 10-3). (b) Survival curve of daf-2(e1370);hpl-2(tm1489) double mutants compared to daf-2(e1370) single mutants.
hpl-2(tm1489) did not further increase daf-2(e1370) mutant lifespan (average lifespan daf-2(e1370), 26.2 ± 0.85 days (n = 95); daf-2(e1370);hpl-2
(tm1489), 24.8 ± 0.97 days (n = 84); log rank test P = 0.271.). (c) Survival curve of daf-16(mu86);hpl-2(tm1489) compared to daf-16(mu86). daf-16
(mu86) mutation suppressed hpl-2(tm1489) mutant lifespan phenotype (average lifespan: daf-16(mu86), 11.9 ± 0.44 days (n = 112); daf-16(mu86);
hpl-2(tm1489), 11.03 ± 0.27 days (n = 109); log rank test P = 0.05).
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transparent, resembling starved animals (data not
shown). This ‘clear’ phenotype has been associated with
decreased fat storage in the intestinal compartment [72].
However, using the neutral lipid dye Oil red O [73], no
reproducible difference in staining intensity was
observed between wild-type and hpl-2 mutant animals
at either permissive or non-permissive temperatures
(Figure 5a, b and data not shown), ruling out any gross
alteration in lipid content.
Quantitative lipid analysis following solid phase
extraction [74] revealed more subtle, highly reproducible
differences in lipid composition in hpl-2 mutant animals
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Figure 5 HPL-2 is a regulator of phospholipid metabolism. (a, b) Oil Red O representative images of wild type (WT) (a) and hpl-2(tm1489)
(b) animals. Worms are F1 progeny of L4 hermaphrodites shifted to 25°C. Images were taken with a CoolSnap Color Camera with 700 ms
exposure time. Scale bar = 50 μm. (c) Simplified overview of phosphatidyl choline (PC) metabolism in C. elegans. P-choline, phosphorylcholine;
CDP-choline, cytidyldiphosphate choline; PC, phosphatidylcholine; PS, phosphatidylserine; PS DC, phosphatidylserine decarboxylase; PE,
phosphatidylethanolamine; Ptd-MeEtn, phosphatidylmonomethylethylamine. Intermediates whose levels are altered in hpl-2 mutant worms
compared to wild type are shown in red. (d) Phospholipid content analysis in wild-type and hpl-2 mutant worms. Bars represent the amount of
each lipid species found as a percentage of the total phospholipid content. PS, phosphatidylserine; PE, phosphatidylethanolamine; PC,
phosphatidylcholine; SM, phingomyelin. Data are the average of two independent cultures. (e) Metabolism of sphingomyelin and ceramide. De
novo sphingomyelin synthesis is mediated by sphingomyelin synthase (SMS), which transfers the phosphorylcholine moiety from
phosphatidylcholine (PC) onto ceramide, forming sphingomyelin and diacylglycerol (DAG). In C. elegans there are three SMS genes, sms-1, -2, and
-3. Ceramide can be generated either by the action of sphingomyelinase (SMase) or by de novo synthesis through the enzyme ceramide
synthase (CerS, lagr-1, hyl-1 and hyl-2 in C. elegans). (f) hpl-2 regulates sms-3 mRNA levels. hpl-2/N2 ratios for sphingomyelin synthase sms genes
at different developmental stages. Experiments were performed on three independent synchronized L3 cultures and on two adult and
embryonic cultures. Reference genes are pmp-3 and cdc-42. Normalization was performed using the mean of both reference genes. Data are the
mean of independent biological replicas.
Meister et al. Genome Biology 2011, 12:R123
http://genomebiology.com/2012/12/12/R123
Page 10 of 18
at the permissive temperature. Consistent with the Oil
red O staining results, no difference in the total content
and composition of neutral lipids was observed and
levels of triacylglycerides and fatty acids were unchanged
in hpl-2 animals compared to wild type (Additional file
12 and data not shown). In contrast, phospholipid analy-
sis showed significant changes in phospholipid content
(Figure 5d). Higher amounts of phosphatidylserine (PS)
were observed in hpl-2 mutant animals, whereas no
increase in phosphatidylethanolamine (PE), the decar-
boxylation product of PS, was observed. These results
may therefore reflect changed expression or function of
PS decarboxylase leading to lower synthesis of PE. Phos-
phatidylcholine (PC) is the predominant membrane lipid
in eukaryotes and also functions in signal transduction
pathways. Although amounts of PC were slightly
reduced in hpl-2 mutant worms, the fact that we do not
observe any obvious defects in hpl-2 mutants at the per-
missive temperature suggests either that the observed
decrease in PC is not large enough to impinge on PC
mediated processes, or that compensatory mechanisms
exist.
Of the different classes of phospholipids analyzed, the
most dramatic change was observed for sphingomyelin
(SM), whose content was reduced by more than 60% in
hpl-2 mutants. SM is a vital component of cellular
membranes and plays an important role in signal trans-
duction and membrane trafficking [75]. Synthesis of SM
involves a transfer of phosphorylcholine from PC to cer-
amide by sphingomyelin-synthases (SMSs; Figure 5E).
Expression of lagr-1, encoding a ceramide synthase
(CerS), is decreased in hpl-2 mutant animals. This could
potentially result in lower levels of ceramide, thereby
influencing SM levels. However, the total content of cer-
amides (hydroxylated and nonhydroxylated) was not
affected in the hpl-2 mutant context (Additional file 12).
Therefore, the decrease in SM levels is more likely to be
due to the down-regulation of de novo SM synthesis
rather than enhanced degradation. C. elegans contains
three SMS homologues, one of which (sms-3) is down-
regulated in hpl-2 mutants. qRT-PCR analysis confirmed
that sms-3 RNA levels are decreased approximately two-
fold with respect to wild type in L3 animals, with a
smaller effect in young adults (Figure 5f). Similarly, sms-
1 levels also appeared to be slightly reduced in L3, but
no significant change in sms-2 RNA levels was observed,
nor were changes in sms-3 or sms-1 levels observed at
the embryonic stage. As shown in Figure 2, ChIP experi-
ments revealed a small but reproducible enrichment of
HPL-2 binding within the sms-3 coding regions in L3
larvae. Therefore, it is likely that HPL-2 directly influ-
ences SM levels through the regulation of sms-3
transcription.
Discussion
Because C. elegans chromosomes are holocentric and
lack centromeric heterochromatin, HP1 proteins are dis-
pensable for chromosome segregation and mitotic viabi-
lity in this organism [23,25]. We have exploited this fact
to examine in detail the role of one of the C. elegans
HP1 homologues, HPL-2, in regulating developmental
pathways of gene expression, a second physiological
function ascribed to heterochromatin. By comparing the
effects of hpl-2 deletion at different stages of develop-
ment, we have shed light on a novel role for this HP1
family member in dauer diapause, longevity and lipid
metabolism. These three processes have in common an
extremely tight response to environmental factors. Thus,
our data link a response to environmental factors to the
epigenetic regulator HPL-2. At least some of the genes
identified in this study are shown by CHIP-on chip to
be bound by HPL-2, and are therefore likely to repre-
sent direct targets.
We show that hpl-2 plays a role in the choice between
dauer and non-dauer development, a striking example of
phenotypic plasticity in which environmental conditions
determine developmental fate. Many of the genes down-
regulated in hpl-2 mutant larvae at the L3 stage show
high expression in wild-type L3 and dramatic reduction
in dauer. These include the cadherins cdh-10 and cdh-12,
the metalloprotease nas-27 and the collagen col-104 [49].
Conversely, genes up-regulated in hpl-2 mutants often
show low expression in wild-type L3 and strong expres-
sion in dauer. Down-regulation of metalloproteases, col-
lagen genes, and Hh-related peptides in hpl-2 mutants
most likely reflects synthesis and remodeling of the cuti-
cle, an important feature of the dauer program. Their
down-regulation in hpl-2 mutants may facilitate entry
into dauer and impair dauer exit, which are the two phe-
notypes we observe in animals lacking HPL-2.
Recently, post-dauer animals have been shown to
have markedly altered genome-wide histone tail modi-
fications, as well as modified gene expression profiles
[76]. Furthermore, mutations of genes implicated in
chromatin function, including hpl-2, were found to
abolish or alter changes in gene expression between
control and post-dauer animals. Remodeling of chro-
matin architecture may therefore play an essential role
in the establishment or maintenance of the post-dauer
expression changes. The inability of hpl-2 worms to
exit dauer suggests that hpl-2 also functions during the
dauer stage to activate the transcriptional program
required to exit this developmental stage and re-enter
the reproductive life cycle. Consistently, we also found
a significant overlap between genes down-regulated in
the absence of HPL-2 and genes whose expression
increases upon dauer exit.
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HPL-2 functions in dauer through the DAF-2/IIS and
the TGF-b pathways. The decision to enter or exit
dauer is mediated by these neuroendocrine signals act-
ing through sensory neurons [40,77]. These in turn reg-
ulate the developmental and metabolic shifts in
remodeled tissues. Although HPL-2 is ubiquitously
expressed, we show using cell type-specific rescue that
HPL-2 is sufficient in either the nervous or the intestinal
system to induce partial rescue of the dauer exit pheno-
type. In the nervous system, it may function to regulate
the activity of widely expressed downstream receptors
and transcription factors, while in intestinal cells it may
more directly mediate the dramatic reshaping of this tis-
sue, a process that can be separated from the remodel-
ing of other tissues [78]. Supporting a cell autonomous
function for HPL-2 in neuronal cells, we find that neu-
ronally expressed genes are significantly overrepresented
in the hpl-2 microarray set (Additional file 3; FET P <
10-9 for up-regulated genes, P < 3.10-3 for down-regu-
lated genes). In both tissues, HPL-2 appears to be
important for environmentally induced changes in tis-
sue-modifying gene expression.
We also show that mutation of hpl-2 leads to a 17%
increase in longevity. RNAi-based screens have identi-
fied a number of additional chromatin regulators as
being important components of longevity, including the
set-9 and set-15 putative H3K9 methyltransferases [79].
More recently, members of an H3K4 histone methyla-
tion complex were also found to regulate lifespan [80],
suggesting that epigenetic mechanisms are likely to play
an important role in the ageing process. In Drosophila,
changes in HP1 copy number were not found to have
any effect on longevity [81]. However, whole genome
profiling has shown a dramatic redistribution of HP1
and H3K9 methylation in aging flies [82]. Similarly,
aging human cells show decreased H3K9me3 and HP1g
staining [83]. Although the specific functional conse-
quences of these age-related changes have not been
directly determined, changes in gene expression are
likely to be involved.
Here we demonstrate that lifespan extension by muta-
tion of hpl-2 depends on both DAF-2 and DAF-16/
FOXO. DAF-16 is a key regulator of longevity, metabo-
lism and dauer diapause, and several microarray experi-
ments have been carried out to identify potential DAF-
16 targets. The requirement for daf-16 activity for the
hpl-2 longevity phenotype could reflect regulation of
some of the same target genes. Although all of the pub-
lished daf-16 microarray studies have been carried out
on adult animals [57,84,85], while our analysis was car-
ried out on early L3 larva, we were nonetheless able to
observe a limited overlap between potential DAF-16 tar-
gets identified by Murphy et al. [57] and hpl-2 regulated
genes. Some of these same genes are also regulated
upon dauer entry, suggesting that HPL-2 may act in
dauer and ageing at least in part through a common
mechanism that is dependent on DAF-16.
The longevity of hpl-2 mutants may also be related to
the function of HPL-2 in repressing germ-cell fate in
the soma. A significant number of genes up-regulated in
L3 larvae in the absence of hpl-2 are germline-expressed
genes, and like long-lived daf-2/IIS mutants [27], hpl-2
mutants show features of soma-to-germline transforma-
tion [28,33]. Soma-to-germline transformation is com-
mon to a number of transcriptional repressors,
including the worm retinoblastoma homolog LIN-35,
E2F components, and members of the worm NuRD
complex, suggesting that HPL-2 may play a direct role
in maintaining germline genes in a repressive chromatin
state [28,33].
The altered levels of lipid metabolic enzyme transcripts
in hpl-2 mutants may represent an additional mechanism
relevant to the observed lifespan increase. HPL-2 regu-
lates the expression of genes involved in fatty acid and
phospholipid metabolism. In mammals, glucose and lipid
homeostasis in almost all major metabolic tissues is regu-
lated in response to nutrient availability by the activity of
the histone deacetylases SIRT1 [86]. Overexpression of
the SIRT1 homolog Sir2 extends lifespan in Saccharo-
myces cerevisiae, C. elegans and Drosophila [87-89], pos-
sibly by altering lipid homeostasis through the conserved
lipid/cholesterol regulator SREBP [90,91]. Our data sug-
gest that HPL-2 may regulate phospholipid metabolism
through regulation of two key enzymes: the sphingomye-
lin synthase gene sms-3 and the ceramide synthase lagr-
1. Expression of sms-3 may be directly up-regulated by
HPL-2, as we are able to detect HPL-2 binding to the
sms-3 coding region. This association is consistent with
growing evidence suggesting that HP1 proteins can also
play positive roles in transcription through binding
within gene bodies [5,11,13,92].
Reduced expression of sms-3 and lagr1 in the absence
of HPL-2 is associated with a 60% reduction in SM
levels. Sphingolipids, including SM and its precursor
ceramide, are cellular membrane components found in
all eukaryotes and implicated in numerous functions,
including the cellular response to environmental stresses
and ageing [75,93-95]. In yeast, the ceramide synthase
component LAG1 was one of the first longevity genes
characterized [96], and subtle changes in ceramide/
sphingolipid metabolism are important in determining
yeast longevity [97]. lagr-1 encodes one of three C. ele-
gans orthologues of yeast LAG1. lagr-1(RNAi) results in
reduced fat content and suppresses alpha-synuclein
inclusions in living and aging animals, a phenotype asso-
ciated with increased longevity [98]. Although neither
lagr-1 nor sms-3 loss of function alone is associated
with increased longevity [99] (FP and YX, data not
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shown), decreasing expression of hyl-1, another worm
homolog of LAG1, increases longevity [99,100], and this
effect is enhanced in hyl-1;lagr-1 double mutants (N
Faergeman, personal communication). Therefore, altered
phospholipid metabolism in the absence of hpl-2 activity
might contribute directly to the longevity phenotype
associated with hpl-2 mutant animals.
Taken together, our results highlight the importance
of epigenetic regulation in the maintenance of homeos-
tasis. As an epigenetic regulator, hpl-2/HP1 could both
stabilize developmental decisions by buffering environ-
mental variation, as well as guide the organism through
remodeling events such as dauer that require plasticity
of cell fate regulation. The signaling pathways that link
HPL-2 to environmental cues are under investigation.
Conclusions
C. elegans provides an optimal system to explore the
roles of HP1 beyond centromeric heterochromatin
because worm chromosomes are holocentric and lack
the alpha satellite repeats that nucleate the binding of
HP1 to centromeres in other species. We have com-
pared expression profiles of wild-type worms and
worms lacking HLP-2, one of this organism’s two HP1
homologues, at two developmental stages. We find that
HPL-2 regulates the expression of germline genes, extra-
cellular matrix components and genes involved in lipid
metabolism. We show that in the soma, HPL-2 is
involved in the dauer developmental decision, which is
tightly linked to environmental conditions. We further
uncover a novel function for HP1-regulated gene
expression in longevity and lipid homeostasis. These
pathways share the characteristic of responding to envir-
onmental cues. We suggest that HPL-2 influences the
expression of genes that regulate developmental pro-
cesses in response to environmental conditions.
Materials and methods
Strains and genetics
Strains were maintained according to the standard pro-
tocol [101]. The following mutant alleles and transgenic
strains were used: LGI, daf-16(mu86); LGIII, hpl-2
(tm1489), daf-2(e1370), daf-7(e1372); LGIV, zIs356 (daf-
16::gfp). The Bristol strain N2 was used as wild type. To
construct the hpl-2(tm1489); zIs356 (daf-16::gfp) strain,
zIs356 (daf-16::gfp) hermaphrodites were mated with
hpl-2 (tm1489) males. F2 worms were screened for the
presence of GFP, and the presence of the hpl-2 deletion
allele was confirmed by PCR analysis as previously
described [23].
Isolation of RNA for microarray analysis
Wild-type and hpl-2(tm1489) gravid adult animals were
synchronized by bleaching. Half of the culture was
collected immediately for RNA extraction from the
embryos. The other half was left to hatch overnight in
M9 without food. Synchronized L1 larvae were then dis-
tributed onto peptone plates, grown at 20°C and staged
until they reached the L3 larval stage (between 28 and
29 hours). The developmental stage was confirmed by
microscopic observation, using both vulval development
and somatic gonad development as criteria.
Triple biological replicates were flash frozen in liquid
N2 and RNA was extracted using the standard Trizol
method followed by RNeasy column purification (Qia-
gen, France, #74104). RNA was labeled and hybridized
to Affymetrix tiling arrays. Washing and scanning were
performed following the manufacturer’s instructions.
Oligos from the tiling array were mapped to chromo-
some coordinates of the exons from Wormbase
WS180. Any oligo that mapped to a gene on both the
Watson and Crick strands was excluded. The remain-
ing oligos were then grouped together (perfect match
and mismatch) into probe sets and written out into an
Affymetrix CDF file. The CDF file was converted into
an R-package and loaded into R. The expression values
were calculated using the justRMA function from Bio-
conductor. This used a Benjamini and Hochberg false
discovery rate correction. The R code is available upon
request.
Quantitative PCR on reverse transcription products
cDNAs were synthesized with a mix of random hexam-
ers and oligo dT primers using iScript cDNA synthesis
kit and 500 ng of RNA (BIO-RAD, France). qPCR reac-
tions on reverse transcription products diluted ten times
were performed using FastStart Universal SYBR Green
Master (Roche, France) and the StepOne Plus Detection
System (Applied Biosystems, France). The qPCR condi-
tions were 95°C for 4 minutes, followed by 40 cycles of
12 s at 95°C and 30 s at 60°C. Melting curve analysis
was performed for each primer set at the end to ensure
the specificity of the amplified product. Standard curves
were generated for each primer set to calculate the effi-
ciency of each set. Only primer sets with an efficiency
between 1.9 and 2.1 were used for qPCR. Primer sets
for the pmp-3 and cdc-42 transcripts were used as inter-
nal controls, and the RNA level of each gene of interest
was normalized to the level of the mean of both these
genes for comparison. qPCR experiments were repeated
at least three times using independent RNA/cDNA pre-
parations. Data were pooled and analyzed using the Ste-
pOne Plus Software (Applied Biosystems). Primer
sequences are available upon request.
Comparisons of different microarray datasets
The P-values for overlaps between lists were generated
by comparison to results of random simulation and by
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calculation based on the hypergeometric distribution as
in [102], using R.
Construction of transgenic lines
For intestinal expression, the hpl-2 (K01G5.2a) full-
length cDNA was cloned into the XbaI-SacII sites of
pJM16 under the control of the ges-1 promoter [103].
For pan-neuronal expression, the cDNA was cloned into
the NotI-SmaI sites of pHU004, under the control of
the rab-3 promoter in fusion with GFP (gift from JL
Bessereau). Both intestinal-specific and neuronal-specific
constructs, named pCB15 and pSS05, respectively, were
injected into N2 hermaphrodites at a concentration of 5
mg/ml using pRF4 as a co-transformation marker at a
concentration of 200 mg/ml. For each construct, two to
three independent transgenic lines were then crossed
with hpl-2(tm1489);daf-2(e1370) males. F2 rollers were
allowed to lay eggs at 15°C, then shifted to 25°C. The F3
were selected for both 100% dauer in the progeny and
the presence of the hpl-2 deletion allele.
Lifespan assay
Lifespan tests were performed at 20°C as described in
[104]. For each genotype, lifespan experiments were
repeated two to four times. Survival analysis was carried
out using the Kaplan Meier method and the significance
of differences between survival curves calculated using
the log rank test. The statistical software used was
XLSTAT 2007 and all P-values < 0.05 were considered
significant.
Chromatin immunoprecipitation
The ChIP protocol was based on [105], with a number of
modifications. L3 staged wild-type or transgenic animals
carrying an integrated rescuing hpl-2::GFP construct [23]
were used as starting material. Worm powder was incu-
bated in phosphate-buffered saline containing 1.5 mM
EGS for 20 minutes at room temperature, followed by
the addition of formaldehyde (1% final) for 10 minutes at
room temperature. After quenching with glycine (125
mM final), the worm pellet was washed in phosphate-
buffered saline, resuspended in lysis buffer (50 mM
HEPES/KOH pH 7.6, 1 mM EDTA, 0.5% sarkosyl, 150
mM KCl, protease inhibitors cocktail (Roche Biochem-
icals) and 1 mM PMSF) and sonicated in a Bioruptor
water bath (Diagenode, Belgium). The homogenate was
centrifuged at 12,000 rpm for 15 minutes at 4°C and the
supernatant containing the sheared chromatin (chroma-
tin extract) precleared twice for 30 minutes at 4°C with
80 μl of a 1:1 slurry of protein A agarose beads (Millipore
#16157, France). The cleared extract was diluted with 2
volumes of FA buffer (50 mM HEPES/KOH pH 7.5, 1
mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate,
150 mM KCl, protease inhibitors cocktail and 1 mM
PMSF). Following incubation with antibodies (anti-HPL-
2 or anti-GFP), 45 μl of a 1:1 slurry of protein A agarose
beads was added to each tube for 1 hour. Beads were
washed twice with FA buffer, once with FA-500 (50 mM
HEPES/KOH pH 7.5, 1 mM EDTA, 1% Triton X-100,
0.1% sodium deoxycholate, 500 mM NaCl), once with
FA-1M (50 mM HEPES/KOH pH 7.5, 1 mM EDTA, 1%
Triton X-100, 0.1% sodium deoxycholate, 1 M NaCl),
once with TEL (0.25 M LiCl, 1% NP-40, 1% sodium
deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.0),
and twice with TE (10 mM Tris/HCl, 1 mM EDTA). Elu-
tion was performed by adding two times 100 μl of elution
buffer (10 mM Tris/HCl, 1 mM EDTA, 250 mM NaCl,
1% SDS) and incubating at 65°C for 10 minutes. Superna-
tants were pooled, incubated for 30 minutes with 1 μl of
RNase A (10 mg/ml) and then incubated overnight at 65°
C with 1 μl of proteinase K (15 to 20 mg/ml). DNA was
recovered using a Qiaquick pure purification kit in 40 μl
of PCR grade water for qPCR analysis. ChIP results were
analyzed by qPCR using primers specific to the sms-3
locus. A primer corresponding to an intergenic region on
chromosome IV was used as control. The anti-GFP anti-
body used was from Abcam, UK (#ab290).
Lipid extraction and analysis
The solid phase extraction procedure was performed as
previously described [74]. Briefly, lipids were extracted
using the Folch procedure [106] and loaded onto a 100
mg aminopropyl LC-NH2 cartridge pre-equilibrated
with 3 ml of hexane, and placed onto a vacuum mani-
fold apparatus (12 port Visiprep, Supelco, Sigma-
Aldrich, France). Neutral lipids (sterols, sterol esters,
methylated fatty acids, tri- and diacylglicerides; fraction
1) were eluted with 1.4 ml hexane:ethylacetate (85:15 v/
v) at a solvent flow rate of 0.3 ml/minute obtained by
applying negative pressure. Ceramides (fraction 2) were
eluted with 1.6 ml of chloroforme:methanol (23:1 v/v).
Free fatty acids (fraction 3) were eluted with 1.8 ml dii-
sopropylether-acetic acid (98:5, v/v), and this fraction
was pooled together with fraction 1. Glycosphingolipids
(fraction 4) were eluted using 2.1 ml of acetone-metha-
nol (9:1.35, v/v). Neutral and acidic phospholipids were
eluted together in one fraction (fraction 5) using 2 ml of
methanol. The fractions were dried under N2 and
resolved by thin layer chromatography using the follow-
ing solvent systems: for separation of neutral lipids and
free fatty acids, hexane:diethylether:acetic acid (80:20:1
v/v/v); for ceramides, chloroform:methanol (50:5 v/v);
for glycosphingolipids, chloroform:methanol:water
(65:25:4 v/v/v); for resolution of phospholipids by two-
dimensional thin layer chromatography, tetrahydrofur-
ane:acetone:methanol:water (50:20:40:6 v/v/v/v) in the
first direction and chloroform:acetone:methanol:acetica-
cid:water in the second direction (50:20:10:15:5 v/v/v/v/
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v). Fractions 1, 2, 3 and 4 were detected after spraying
with cupric sulfate and charred at 180°C for 5 minutes.
Phospholipids were detected by iodine and scraped into
glass tubes. Lipidic phosphorous was mineralized by
warming the samples in 0.25 ml mixture of sulfuric
acid:perchloric acid (2:1 v/v) containing vanadium tetra-
oxide (1 g/l) for 20 s above the flame and quantified by
5 ml of reagent containing 0.63 g of ANSA mixture, 0.2
g ammonium heptamolybdate in 100 ml of water
(ANSA contains 60 g of sodium metabisulfate, 2 g of
sodium sulfate and 1 g of 1-amino 2-naphtol 4-sulfonic
acid). Samples were mixed by vortexing, incubated at
100°C for 8 minutes and absorbances were read at 830
nm. Standard curves were made by the use of monopo-
tassium phosphate.
Data availability
Microarray data are publicly available through NCBI,
Gene Expression Omnibus accession number
[GSE33700].
Additional material
Additional file 1: Differentially expressed genes for embryos and L3
stage larvae in wild type compared to hpl-2 mutant animals.
Additional file 2: Increased lin-13::GFP expression in the absence of
HPL-2 activity. Expression of a lin-13::GFP translational fusion [108] in
wild-type and hpl-2 mutant animals. In hpl-2 mutant animals GFP
expression was particularly strong in nuclei in the head region (arrows).
Additional file 3: HPL-2 regulation of specific gene classes. (a-f)
Venn diagrams showing overlap between: (a) genes up-regulated in L3
stage hpl-2 mutants and germline genes; (b) genes down-regulated in L3
stage hpl-2 mutants and genes induced in dauer exit; (c) genes down-
regulated in L3 stage hpl-2 mutants and genes clustered in expression
mountain 29 of the C. elegans three-dimensional topographical
expression map; (d) genes regulated in L3 stage hpl-2 mutants and
neuronally expressed genes; (e) genes down-regulated in L3 stage hpl-2
mutants and daf-16 target genes; (f) genes down-regulated in L3 stage
hpl-2 mutants and aging regulated genes.
Additional file 4: Overlap between hpl-2-regulated genes and genes
bound by HPL-2. Venn diagram showing overlap between genes
regulated in L3 stage hpl-2 mutants and genes bound by HPL-2 [29].
Additional file 5: HPL-2 and H3K9me3 are enriched on repetitive
transgenes. (a) Histogram representing the percentage of
immunoprecipitation, calculated as the ratio between signal from the
antibodies and signal from pre-immune serum, from ChIP experiments
along a repetitive transgene. Synchronized populations of L3 wild-type or
hpl-2 mutant worms carrying the trangene were subjected to
immunoprecipitation using anti-HPL-2, anti-H3K9me3, or pre-immune
serum as control. (b) Schematic representation of the transgene used in
these experiments [109] showing the position of the primers used for
qPCR analysis. Similar results were obtained for three to four
independent experiments.
Additional file 6: Repressive histone mark levels on promoters and
genes misregulated in hpl-2 mutant worms. For each gene or gene
promoter, H3K9 mono-, di- and tri-methyl levels were calculated as the
median level observed on the DNA stretch using data provided by the
modENCODE Consortium [29]. The criterion for choosing control genes
was similar expression levels. Data are presented as box-whisker
representation where the bar indicates the median of all up- or down-
regulated genes and the upper and lower edges of the box represent
the 25th and 75th percentiles, respectively. Up-regulated genes show a
significantly higher level of mono-, di- and tri-methylated H3K9, but no
enrichment in H3K27 trimethylation, compared to expression-matched
control genes. Down-regulated genes show a similar level of mono-, di-
and tri-methylated H3K9 compared to expression-matched control genes.
Additional file 7: rab-3p::hpl-2cDNA::GFP transgene is expressed
uniquely in neuronal cells. GFP fluorescence is detected in the
synaptic-rich regions of the nervous system, including the nerve ring,
ventral nerve cord, and dorsal nerve cord (arrowheads).
Additional file 8: Increased lifespan of hpl-2(RNAi) animals. Animals
at the L4 stage were placed on RNAi or control bacteria at 20°C and
allowed to lay eggs. When F1 progeny reached the L4 stage, they were
transferred to 25°C for lifespan assays on plates containing 10 μM 5FU.
Worms were then transferred to fresh RNAi plates every week. hpl-2 RNAi
increased average lifespan by 18% (average lifespans: wild type fed
control bacteria, 10.3 ± 0.42 (n = 60); wild type fed hpl-2 RNAi clone 1,
12.2 ± 0.32 days (n = 60; control comparison P = 10-3). Similar results
were obtained in two independent tests.
Additional file 9: hpl-2 deletion does not affect the total number of
germ cells produced. Data are displayed as the mean (± standard
deviation) number of germ cells per gonad arm (n = 4). Germ cell
number was obtained by counting germ cell nuclei stained with DAPI in
dissected gonads of young adults.
Additional file 10: hpl-2 does not influence DAF-16::GFP localization.
Adults carrying a daf-16::gfp transgene (zIs356) were placed on NGM
plates at 37°C. After 45 minutes, worms were mounted onto a slide in
M9 buffer. Nuclear translocation of DAF-16::GFP was visualized with a
fluorescence microscope AxioImager Z1 (Zeiss) equipped with a
CoolSnap HQ camera and driven by Metamorph software (Molecular
Devices, France).
Additional file 11: The hpl-2(tm1489) deletion mutant does not
affect resistance to oxidative stress. Adult hermaphrodites were
incubated in M9 buffer with 100 mM paraquat. After incubation at 20°C
for the specified duration, survival was measured. Worms were scored as
dead when they did not respond to a mechanical stimulus. The
experiment was performed three times. Mean fraction alive indicates the
average survival among the multiple trials and the error bar represents
the standard deviation. P-value was calculated using Student’s t-test.
Additional file 12: hpl-2 does not influence levels of ceramides and
neutral lipids. (a) Ceramides (elution fraction 2) isolated from wild-type
and hpl-2 animals were loaded on thin layer chromatography plates and
run in a chloroform:methanol (50:5) solvent system. (b) Neutral lipids
(elution fraction 1 and 3) were deposited on thin layer chromatography
plates and run in hexane:diisopropylether:acetic acid (80:20:1).
Abbreviations
ChIP: chromatin immunoprecipitation; FET: Fisher exact test; GFP: green
fluorescent protein; GO: Gene Ontology; H3K9: histone H3 lysine 9;
H3K9me3: tri-methylated lysine 9 of histone H3; Hh: Hedgehog; Hp:
Heterochromatin protein; IIR: insulin/insulin-like growth factor-I-like receptor;
PC: phosphatidylcholine; PE: phosphatidylethanolamine; PMSF:
phenylmethanesulfonylfluoride; PS: phosphatidylserine; qPCR: quantitative
PCR; qRT-PCR: quantitative reverse-transcriptase PCR; RNAi: RNA interference;
SM: sphingomyelin; TGF: transforming growth factor.
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